The category of SERHL activators have broad-spectrum effects on serine hydrolases, influencing SERHL proteins as part of this larger group. Serine hydrolases, characterized by their active site serine residue, play critical roles in various biological processes. Chemicals like AEBSF, PMSF, and DFP are known to inhibit serine hydrolases by interacting with this serine residue. These inhibitors are useful tools for studying the function of serine hydrolases, including SERHL proteins, by observing the effects of inhibition on cellular processes.
Advanced chemical probes like FP-biotin are used to label serine hydrolases for study, providing insight into their activity and regulation. Compounds such as MAFP and Bortezomib, although not specific to SERHL proteins, offer a broader perspective on how serine hydrolases function and are regulated within the cell. Understanding the impact of these inhibitors and modulators on serine hydrolases, including SERHL proteins, is crucial for elucidating their roles in physiology and pathology. These compounds aid in dissecting the complex mechanisms of action of serine hydrolases and offer pathways for intervention in diseases where these enzymes are dysregulated. However, the need for more specific and targeted activators for SERHL proteins remains an area for future research and development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
A broad-spectrum serine protease inhibitor that may affect serine hydrolases. | ||||||
Phenylmethylsulfonyl Fluoride | 329-98-6 | sc-3597 sc-3597A | 1 g 100 g | $50.00 $697.00 | 92 | |
A widely used serine protease inhibitor that could potentially inhibit serine hydrolase-like proteins. | ||||||
KI 8751 | 228559-41-9 | sc-203090 | 5 mg | $142.00 | 2 | |
A potent inhibitor of several serine hydrolases, including lipases and esterases. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
While primarily a proteasome inhibitor, Bortezomib may affect certain serine hydrolases. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
An inhibitor of cysteine proteases that might have off-target effects on serine hydrolases. | ||||||
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
A synthetic protease inhibitor that may interact with serine hydrolases. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
An inhibitor of both cysteine and serine proteases. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that may have secondary effects on serine hydrolases. | ||||||
Omi/HtrA2 Protease Inhibitor, Ucf-101 | 313649-08-0 | sc-222101 | 10 mg | $200.00 | 1 | |
Known to inhibit specific serine hydrolases like Omi/HtrA2. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
A pan-caspase inhibitor that could have effects on certain serine hydrolases. | ||||||